Shortage in ADHD medication is reported from September 2023

GPs have been advised not to start new patients on several drugs for treating attention deficit/hyperactivity disorder that are in short supply in the UK, the Department of Health and Social Care said, due to a combination of manufacturing problems and increasing global demand. www.bmj.com

Shortages reported in the following:

Methylphenidate:

• Equasym XL® 10, 20 and 30 mg capsules

• Xaggitin XL® 18 and 36 mg prolonged-release tablets

• Concerta XL® 54 mg prolonged-release tablets

• Xenidate XL® 27 mg prolonged-release tablets

Lisdexamfetamine:

• Elvanse® 20, 30, 40, 50, 60 and 70 mg capsules

• Elvanse® Adult 30, 50, and 70 mg capsules

Guanfacine:

• Intuniv® 1, 2, 3 and 4 mg prolonged-release tablets

If your medication is currently affected by the shortage and you require a prescription, you have the following options: Shortage in ADHD medication is reported from September 2023

1. Get the prescriptions sent directly to your home, or pick them up in our clinic, and contact local pharmacies. Some pharmacies may have stock remaining or restock small quantities.

2. Book a medication review to get changed to a different medication during the time of the shortage.

3. Wait until your medication is back in stock.

Credit https://adhddirect.co.uk/blog/uk-wide-and-global-shortage-of-elvanse-and-atomoxetine/www.adhddirect.co.uk